Longaeva Partners »

Sionna Therapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $509k 13k 40.09

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Viking Global Investors
Atlas Venture Life Science Advisors
Enavate Sciences GP
Jennison Associates
BlackRock
Vanguard Group
Citadel Advisors
Vanguard Capital Management
Deerfield Management Company
State Street Corporation
Perceptive Advisors
Eventide Asset Management

View all funds holding Sionna Therapeutics